Blog
RSS FeedPosted by Michael Wonder on 08 Nov 2024
Newly funded medicine to benefit 110 more people with thyroid, liver, and kidney cancer
8 November 2024 - PHARMAC has decided to fund lenvatinib from 1 December 2024 for people with some types of ...
Posted by Michael Wonder on 07 Nov 2024
PHARMAC publishes agenda for the November 2024 PTAC meeting
6 November 2024 - PHARMAC has published the agenda for the upcoming 14-15 November 2024 PTAC meeting. ...
Posted by Michael Wonder on 01 Nov 2024
10,000 New Zealanders set to benefit from PHARMAC budget increase
1 November 2024 - Thirteen new medicines funded from today will benefit thousands of New Zealanders with various health conditions ...
Posted by Michael Wonder on 31 Oct 2024
PHARMAC looks to fund a medicine to keep bones strong
31 October 2024 - PHARMAC is consulting on a proposal to widen access to denosumab for more people with osteoporosis and ...
Posted by Michael Wonder on 18 Oct 2024
PHARMAC seeking bids from suppliers for COVID-19 vaccines
17 October 2024 - PHARMAC is seeking bids from pharmaceutical suppliers of COVID-19 vaccines. ...
Posted by Michael Wonder on 10 Oct 2024
PHARMAC improves access to three cancer medicines
10 October 2024 - PHARMAC will improve access to three cancer medicines from 1 November 2024. ...
Posted by Michael Wonder on 08 Oct 2024
Updated information about PHARMAC's priority lists
8 October 2024 - PHARMAC’s quarterly Pūahoaho Report provides the latest information about applications for medicines, vaccines, and related products that ...
Posted by Michael Wonder on 01 Oct 2024
Rollout of new medicines across New Zealand begins
1 October 2024 - Today marks the first day a range of new medicines, including cancer medicines, will start to ...
Posted by Michael Wonder on 01 Oct 2024
New Zealand Pharmaceutical Schedule - 1 October 2024
1 October 2024 - The October 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 27 Sep 2024
Thousands benefit from PHARMAC decision to fund oestradiol gel
26 September 2024 - PHARMAC has decided to fund oestradiol gel, a type of hormone treatment, it estimates 18,000 people will ...
Posted by Michael Wonder on 24 Sep 2024
Improved access to medicines for urinary tract infections and Parkinson's disease
24 September 2024 - PHARMAC is widening access to a medicine to treat urinary tract infections and funding a combination ...
Posted by Michael Wonder on 18 Sep 2024
Making more new cancer treatments available for New Zealanders
18 September 2024 - PHARMAC is consulting on a proposal to fund the medicine lenvatinib mesylate for three types of cancer ...
Posted by Michael Wonder on 17 Sep 2024
5,700 people to benefit from widened access to funded medicines
17 September 2024 - PHARMAC is widening access to seven medicines, benefitting an estimated 5,700 people within the first year ...
Posted by Michael Wonder on 13 Sep 2024
Proposal to fund medicines for lung cancer, breast cancer, and respiratory conditions
13 September 2024 - PHARMAC is seeking feedback on a proposal to fund four new medicines for cancer and respiratory ...
Posted by Michael Wonder on 11 Sep 2024
New medicine and an easier renewal process proposed for people with ADHD
12 September 2024 - PHARMAC is asking for feedback on two changes for people with attention deficit hyperactivity disorder - ...